Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine plus Cetuximab vs Gemcitabine in Advanced Pancreatic Cancer
NCT00075686Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2004
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of KL-140 in pancreatic adenocarcinoma (PDAC), sponsored by SWOG Cancer Research Network. Started Jan 2004; status: completed.
02
Drugs
KL-140
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00075686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075686.